Carlos Torrado

The University of Texas MD Anderson Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Poly(ADP-Ribose) Polymerase Inhibitor Development: Promising Strategies to Move Beyond Approved Indications”.

Poly(ADP-Ribose) Polymerase Inhibitor Development: Promising Strategies to Move Beyond Approved Indications

JCO Precision Oncology(2024)10.1200/po.24.00204

N/A

0DataRank · unranked

2 citations

Ruth Plummer, Timothy A. Yap, Carlos Torrado

Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma

npj Precision Oncology(2025)10.1038/s41698-025-01025-1

N/A

0DataRank · unranked

3 citations

Ian M. Silverman, Adrienne Johnson, Chenfeng Meng, Joseph D. Schonhoft, Michal Zimmermann +10 more